Aslan Pharmaceuticals Inc. (NASDAQ: ASLN) stock declines during pre-market. Here’s what’s happening?
Aslan Pharmaceuticals Inc. (NASDAQ: ASLN) stock plunged by 1.77% at last close while the ASLN stock price keeps falling by 6.12% in the pre-market session as well. ASLAN Pharmaceuticals is a clinical-stage immunology biopharmaceutical corporation focusing on discovering novel therapies to improve patients’ lives. ASLAN’s product pipeline includes ASLAN004, a first-in-class monoclonal therapy being formulated […]
